BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16706930)

  • 21. MTHFR A1298C and C677T gene polymorphisms and susceptibility to chronic myeloid leukemia in Egypt.
    Aly RM; Taalab MM; Ghazy HF
    Int J Clin Exp Pathol; 2014; 7(5):2571-8. PubMed ID: 24966971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MTHFR polymorphisms and risk of chronic lymphocytic leukemia.
    Rudd MF; Sellick GS; Allinson R; Matutes E; Catovsky D; Houlston RS
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2268-70. PubMed ID: 15598791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between methylene tetrahydrofolate reductase and glutathione S-transferase M1 gene polymorphisms and chronic myeloid leukemia in a Brazilian population.
    Lordelo GS; Miranda-Vilela AL; Akimoto AK; Alves PC; Hiragi CO; Nonino A; Daldegan MB; Klautau-Guimarães MN; Grisolia CK
    Genet Mol Res; 2012 Apr; 11(2):1013-26. PubMed ID: 22576927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults.
    Liu P; Zhang M; Xie X; Jin J; Holman CD
    Tumour Biol; 2016 Mar; 37(3):3265-75. PubMed ID: 26438060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
    Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
    Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between the methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia in Serbian children.
    Damnjanovic T; Milicevic R; Novkovic T; Jovicic O; Bunjevacki V; Jekic B; Lukovic L; Novakovic I; Redzic D; Milasin J
    J Pediatr Hematol Oncol; 2010 May; 32(4):e148-50. PubMed ID: 20445408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway.
    Martínez ME; Thompson P; Jacobs ET; Giovannucci E; Jiang R; Klimecki W; Alberts DS
    Gastroenterology; 2006 Dec; 131(6):1706-16. PubMed ID: 17087956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women.
    Barbosa PR; Stabler SP; Machado AL; Braga RC; Hirata RD; Hirata MH; Sampaio-Neto LF; Allen RH; Guerra-Shinohara EM
    Eur J Clin Nutr; 2008 Aug; 62(8):1010-21. PubMed ID: 17522601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia.
    Kamel AM; Moussa HS; Ebid GT; Bu RR; Bhatia KG
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):96-105. PubMed ID: 19034339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.
    Timuragaoglu A; Dizlek S; Uysalgil N; Tosun O; Yamac K
    Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
    Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of MTHFR and TPMT genes in susceptibility to childhood acute lymphoblastic leukemia (ALL) in Mexicans.
    Gutiérrez-Álvarez O; Lares-Asseff I; Galaviz-Hernández C; Reyes-Espinoza EA; Almanza-Reyes H; Sosa-Macías M; Chairez Hernández I; Salas-Pacheco JM; Bailón-Soto CE
    Drug Metab Pers Ther; 2016 Mar; 31(1):41-6. PubMed ID: 26845729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE).
    Amigou A; Rudant J; Orsi L; Goujon-Bellec S; Leverger G; Baruchel A; Bertrand Y; Nelken B; Plat G; Michel G; Haouy S; Chastagner P; Ducassou S; Rialland X; Hémon D; Clavel J
    Cancer Causes Control; 2012 Aug; 23(8):1265-77. PubMed ID: 22706675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphocytic leukemia in an Indian population.
    Reddy H; Jamil K
    Leuk Lymphoma; 2006 Jul; 47(7):1333-9. PubMed ID: 16923565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrations in folate metabolic pathway and altered susceptibility to autism.
    Mohammad NS; Jain JM; Chintakindi KP; Singh RP; Naik U; Akella RR
    Psychiatr Genet; 2009 Aug; 19(4):171-6. PubMed ID: 19440165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in greek patients.
    Chatzidakis K; Goulas A; Athanassiadou-Piperopoulou F; Fidani L; Koliouskas D; Mirtsou V
    Pediatr Blood Cancer; 2006 Aug; 47(2):147-51. PubMed ID: 16123993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylenetetrahydrofolate reductase genotype association with the risk of follicular lymphoma.
    Ismail SI; Ababneh NA; Khader Y; Abu-Khader AA; Awidi A
    Cancer Genet Cytogenet; 2009 Dec; 195(2):120-4. PubMed ID: 19963111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children.
    Mosaad YM; Abousamra NK; Elashery R; Fawzy IM; Eldein OA; Sherief DM; El Azab HM
    Leuk Lymphoma; 2015; 56(9):2699-705. PubMed ID: 25629981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Association between methylene-tetrahydrofolate reductase gene polymorphisms and chronic myeloid leukemia].
    Dorgham S; Aberkane M; Boughrara W; Antar Soltan B; Mehalhal N; Touhami H; Sidimansour N; Merad Boudia N; Louhibi L; Boudjema A
    Bull Cancer; 2014 Sep; 101(9):803-7. PubMed ID: 25036376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.